Publication Type : Journal Article
Publisher : Clin Trans Immunol
Source : Clin Trans Immunol. 2022
Url : https://pubmed.ncbi.nlm.nih.gov/35356066/
Campus : Faridabad
Center : Amrita Research Center Delhi
Year : 2022
Abstract : Group 2 innate lymphoid cells ILC2 are a relatively new class of innate immune cells. Lung ILC2 are early responders that secrete type 2 cytokines in response to danger 'alarmin' signals such as interleukin (IL)-33 and thymic stromal lymphopoietin. Being an early source of type 2 cytokines, ILC2 are a critical regulator of type 2 immune cells of both innate and adaptive immune responses. The immune regulatory functions of ILC2 were mostly investigated in diseases where T helper 2 inflammation predominates. However, in recent years, it has been appreciated that the role of ILC2 extends to other pathological conditions such as cancer and viral infections. In this review, we will focus on the potential role of lung ILC2 in the induction of mucosal immunity against influenza virus infection and discuss the potential utility of ILC2 as a target for mucosal vaccination.
Cite this Research Publication : Williams, C.M., Roy, S., Sun, W., Furuya, A.M., Wijesundara, D.K., Furuya, Y. Lung group 2 innate lymphoid cells as a new adjuvant target to enhance intranasal vaccine efficacy against influenza. Clin Trans Immunol. 2022